TITLE

A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study

AUTHOR(S)
Prosser, James M.; Yard, Samantha; Steele, Annie; Cohen, Lisa J.; Galynker, Igor I.
PUB. DATE
January 2009
SOURCE
BMC Psychiatry;2009, Vol. 9, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Because a large proportion of patients with panic attacks receiving approved pharmacotherapy do not respond or respond poorly to medication, it is important to identify additional therapeutic strategies for the management of panic symptoms. This article describes a randomized, rater-blind study comparing low-dose risperidone to standard-of-care paroxetine for the treatment of panic attacks. Methods: Fifty six subjects with a history of panic attacks were randomized to receive either risperidone or paroxetine. The subjects were then followed for eight weeks. Outcome measures included the Panic Disorder Severity Scale (PDSS), the Hamilton Anxiety Scale (Ham-A), the Hamilton Depression Rating Scale (Ham-D), the Sheehan Panic Anxiety Scale-Patient (SPAS-P), and the Clinical Global Impression scale (CGI). Results: All subjects demonstrated a reduction in both the frequency and severity of panic attacks regardless of treatment received. Statistically significant improvements in rating scale scores for both groups were identified for the PDSS, the Ham-A, the Ham-D, and the CGI. There was no difference between treatment groups in the improvement in scores on the measures PDSS, Ham- A, Ham-D, and CGI. Post hoc tests suggest that subjects receiving risperidone may have a quicker clinical response than subjects receiving paroxetine. Conclusion: We can identify no difference in the efficacy of paroxetine and low-dose risperidone in the treatment of panic attacks. Low-dose risperidone appears to be tolerated equally well as paroxetine. Low-dose risperidone may be an effective treatment for anxiety disorders in which panic attacks are a significant component. Trial Registration: ClinicalTrials.gov Identifier: NCT100457106
ACCESSION #
42408653

 

Related Articles

  • Encephalopathy resembling Creutzfeldt-Jakob disease following oral, prescribed doses of bismuth nitrate. Von Bose, Michael J.; Zaudig, Michael; Von Bose, M J; Zaudig, M // British Journal of Psychiatry;Feb91, Vol. 158, p278 

    A patient given bismuth nitrate in the recommended dose range over 16 months developed panic attacks and a major depressive syndrome and, after 15 months, a myoclonic encephalopathy resembling Creutzfeldt-Jakob disease. He recovered four months after bismuth had been discontinued. Bismuth...

  • New fellowship for psychiatric research. Delamothe, Tony // BMJ: British Medical Journal (International Edition);8/12/89, Vol. 299 Issue 6696, p414 

    Focuses on the formation of a fellowship for psychiatric research in Edinburgh, Scotland. Biochemical aspects of depressive illness; Effects of glucocorticoids on central monoamine functions; Discussion of psychiatric problems.

  • Beating the blues. Worden, Jeni // Health & Homeopathy;Jan2010, p22 

    The article focuses on the use of homeopathic remedies for symptoms of depression and anxiety. She mentions the use of Arsenicum album especially with concomitant gastric symptoms and panic attacks. She suggests that Ignatia is useful for depression following bereavement. She mentions using...

  • Trazodone.  // AHFS Consumer Medication Information;May2020, p1 

    Trazodone is used to treat depression. Trazodone is in a class of medications called serotonin modulators. It works by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.

  • Panic attacks as risk markers for mental disorders*. Baillie, Andrew J.; Rapee, Ronald M. // Social Psychiatry & Psychiatric Epidemiology;Mar2005, Vol. 40 Issue 3, p240 

    Objective: This paper extends previous epidemiological findings linking panic attacks with future episodes of depression and examines whether this relationship is independent of the effects of gender and neuroticism.Methods: Composite International Diagnostic Interview...

  • ask dr judy. Moss, Judy // Good Health & Medicine;Nov2007, p164 

    The article provides an answer to a question about depression, nerves and panic attacks.

  • SMOKE GETS IN YOUR MIND. Petit-Zeman, Sophie // New Scientist;4/13/2002, Vol. 174 Issue 2338, p30 

    Presents the campaign of tobacco industry to lift personal mood and soothe anxiety. Consequences of clinical depression; Effects of schizophrenia drugs; Risk of panic attack with smoking.

  • Relieving burden posed by anxiety. Cocdyre, David // New Zealand Doctor;11/4/2009, p20 

    The article presents a medical case of a Samoan man with panic attacks. He was diagnosed with panic disorder and treated with paroxetine. He was followed up to monitor his progress and was referred to a local cognitive-behavioral therapy (CBT) provider to assist him with psychoeducation with...

  • A controlled comparison of simulated and real ECT. Lambourn, J.; Gill, D. // British Journal of Psychiatry;Dec78, Vol. 133, p514 

    Two groups of 16 patients with depressive psychosis took part in a controlled evaluation of electro-convulsive therapy (ECT). One group received six brief pulse unilateral shocks under conventional anaesthesia and muscle relaxation; the second group underwent the same procedure without receiving...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics